Home › NDC Lookup › RxCUI directory › RxCUI 2685263

Brompheniramine maleate 0.2 MG/ML Oral Solution — RxCUI 2685263

RxNorm drug concept · Semantic clinical drug
RxCUI 2685263 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2685263
Official nameBrompheniramine maleate 0.2 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbrompheniramine maleate 2 MG per 10 ML Oral Solution; brompheniramine maleate 2 MG in 10 mL Oral Solution
FDA products mapped2
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Brompheniramine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It temporarily relieves hay fever symptoms. That means runny nose, sneezing, itching of the nose or throat, and itchy, watery eyes. It treats symptoms for a short time.
  • The label directs a dose about every 4 hours, but no more than 6 doses in 24 hours. Use only the dosage cup that comes with it, and follow the age-based directions on your bottle....
  • It might. Drowsiness can happen, so be careful driving or using machinery. Avoid alcohol, sedatives, and tranquilizers because they can make it worse.
  • No. The label says never to use it to sedate a child or make a child sleepy. Some children get excitable instead of drowsy.
📖 Read our full Brompheniramine guide →

🕸️ Concept Web — How Brompheniramine maleate 0.2 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Brompheniramine maleate 0.2 MG/ML Oral Solution RxCUI 2685263

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Brompheniramine 1767
    • Brompheniramine maleate 142427
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Brompheniramine Oral Solution 374535
    • Brompheniramine maleate Oral Solution 2648499
    • Brompheniramine Oral Liquid Product 1156060
    • Brompheniramine Oral Product 1156061
    • Brompheniramine maleate Oral Liquid Product 2660908
    • Brompheniramine maleate Oral Product 2659222
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Brompheniramine maleate 0.2 MG/ML 1053257

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Brompheniramine maleate 0.2 MG/ML SCDC · 1053257
  • Brompheniramine Oral Solution SCDF · 374535
  • Brompheniramine maleate Oral Solution SCDFP · 2648499
  • Brompheniramine Oral Liquid Product SCDG · 1156060
  • Brompheniramine Oral Product SCDG · 1156061
  • Brompheniramine maleate Oral Liquid Product SCDGP · 2660908
  • Brompheniramine maleate Oral Product SCDGP · 2659222

📦 FDA Products & Package NDCs

2 products · 3 package NDCs
3 package NDCs map to RxCUI 2685263 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
51316-0693-04 1 BOTTLE in 1 CARTON (51316-693-04) / 118 mL in 1 BOTTLE CVS PHARMACY Childrens Cold and Allergy CVS PHARMACY, INC. 2025-02-24
69536-0305-04 1 BOTTLE in 1 CARTON (69536-305-04) / 118 mL in 1 BOTTLE Dimetapp Cold and Allergy Foundation Consumer Healthcare 2024-06-15
69536-0305-08 1 BOTTLE in 1 CARTON (69536-305-08) / 237 mL in 1 BOTTLE Dimetapp Cold and Allergy Foundation Consumer Healthcare 2024-06-15
Observed labelers: Foundation Consumer Healthcare (2) · CVS PHARMACY, INC. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.